Anticholinergic Drug Exposure and the Risk of Dementia-Reference-Cited by-同舟云学术

Anticholinergic Drug Exposure and the Risk of Dementia

Published:2019-08-01 Issue:8 Volume:179 Page:1084
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

Coupland Carol A. C.¹,Hill Trevor¹,Dening Tom²,Morriss Richard²,Moore Michael³,Hippisley-Cox Julia¹⁴

Affiliation:

1. Division of Primary Care, University of Nottingham, Nottingham, England

2. Division of Psychiatry and Applied Psychology, Institute of Mental Health, Nottingham, England

3. University of Southampton Medical School, Primary Care and Population Sciences, Aldermoor Health Centre, Southampton, England

4. Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, England

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Link

https://jamanetwork.com/journals/jamainternalmedicine/article-pdf/179/8/1084/17754718/jamainternal_coupland_2019_oi_190025.pdf

Reference43 articles.

1. Dementia prevention, intervention, and care.;Livingston;Lancet,2017

2. 2018 Alzheimer’s disease facts and figures.;Alzheimer’s Association;Alzheimers Dement,2018

3. Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study.;Fox;J Am Geriatr Soc,2011

4. Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review.;Fox;Age Ageing,2014

5. Drugs with anticholinergic properties: a current perspective on use and safety.;Gerretsen;Expert Opin Drug Saf,2011

Cited by 429 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Attitudes and beliefs towards medication burden and deprescribing in Parkinson disease;BMC Neurology;2024-09-06

2. Anticholinergic load: A commonly neglected and preventable risk to cognition during schizophrenia treatment?;Schizophrenia Research: Cognition;2024-09

3. Frailty, Specialized Care, and Sociodemographic Factors: Disparities in Oral Pharmacotherapy Class Utilization Among Medicare Part D Beneficiaries With Overactive Bladder in the United States;Urology;2024-09

4. Prevalence of strong anticholinergic use in residents with and without cognitive impairment and frailty: analysis from 106 nursing homes in 12 Asia-Pacific and European countries;Archives of Gerontology and Geriatrics;2024-09

5. Safe Deprescribing of Antidepressants;The Maudsley Deprescribing Guidelines – Antidepressants, Benzodiazepines, Gabapentinoids and Z‐drugs;2024-08-30